Advertisement
Advertisement

ENTX

ENTX logo

Entera Bio Ltd. Ordinary Shares

3.00
USD
Sponsored
+0.05
+1.69%
Sep 04, 15:59 UTC -4
Closed
exchange

After-Market

2.89

-0.11
-3.63%

ENTX Earnings Reports

Positive Surprise Ratio

ENTX beat 23 of 31 last estimates.

74%

Next Report

Date of Next Report
Nov 12, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$0.08
Implied change from Q2 26 (Revenue/ EPS)
--
/
-42.86%
Implied change from Q3 25 (Revenue/ EPS)
--
/
+14.29%

Entera Bio Ltd. Ordinary Shares earnings per share and revenue

On Aug 07, 2026, ENTX reported earnings of -0.14 USD per share (EPS) for Q2 26, missing the estimate of -0.08 USD, resulting in a -71.57% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.92% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.08 USD, with revenue projected to reach -- USD, implying an decrease of -42.86% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Clinuvel Pharmaceuticals Limited - ADR
Report Date
Aug 27, 2026 For Q4 26
Estimate
$0.50
Actual
-
Surprise
-
logo
Anavex Life Sciences
Report Date
Aug 25, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+1.96%
logo
Molecular Partners AG - ADR
Report Date
Aug 25, 2026 For Q2 26
Estimate
-
Actual
-$0.35
Surprise
-
FAQ
For Q2 2026, Entera Bio Ltd. Ordinary Shares reported EPS of -$0.14, missing estimates by -71.57%, and revenue of $0.00, 0% as expectations.
The stock price moved up 5.92%, changed from $2.87 before the earnings release to $3.04 the day after.
The next earning report is scheduled for Nov 12, 2026.
Based on 3 analysts, Entera Bio Ltd. Ordinary Shares is expected to report EPS of -$0.08 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement